Nonprofit Basics: Conflict of Interest Policies and Best Practices for Approving Insider Compensation
How to Prevent Executives from Saying the Wrong Thing When Testifying
Monthly Minute | Environmental, Social, & Governance (ESG) Programs
Welcome to 'Just Compensation'
Williams Mullen's COVID-19 Comeback Plan: 10 Pandemic-Influenced Operations, M&A and Finance Ideas for Executives
Creating Sustainable Models for Social Change with Ashleigh Huffman, Ph.D., U.S. State Department: On Record PR
Working Together: Tips for Ensuring A Compliant Relationship Between You and Your Hospice Board
Leaders Moving 2020 Forward with Julia Haart of Elite World Group
What it takes to be a corporate COO, mother, blogger, and leader with Sigalle Barness of Lawline: On Record PR
Is the #MeToo Movement Over? - Employment Law This Week® - Trending News
Compliance Into The Weeds: Episode 113-Corporate Governance Nightmare
FCPA Compliance Report-Episode 334, Lauren Briggerman
In April, we issued an alert discussing the U.S. Securities and Exchange Commission ("SEC") and Department of Justice’s ("DOJ") expansion of insider trading to 10b5-1 plans. On June 21, 2024, a federal jury in California...more
As discussed in our March 3, 2023 post, the DOJ and SEC brought an insider trading case against the founder and former CEO and Executive Chairman of Ontrak, Inc. based upon the former executive failing the “clean hands”...more
Over the last several weeks, federal regulators and prosecutors have sent a strong signal to company executives that they will be using every tool in their arsenal to combat insider trading. The government’s crackdown has...more
On March 1, 2023, the U.S. Department of Justice (DOJ) unsealed an indictment against the CEO of a publicly traded healthcare company (the Executive) relating to charges of an insider trading scheme. The indictment represents...more
Last week, the US Securities and Exchange Commission’s (SEC) Investor Advisory Committee (IAC) issued recommendations that the SEC impose new restrictions and disclosure requirements for trading plans that afford executives...more
Rule 10b5-1 trading plans have faced increased scrutiny since the onset of the COVID-19 pandemic and the corresponding public focus on stock sales by executives of public life sciences companies. On June 7, 2021, SEC Chairman...more
There has been significant discussion lately about the need to restrict or improve the disclosure of trades made by corporate executives under 10b5-1 plans. In late 2019, I co-authored a series for Corporate Counsel...more